Ex-OpenAI exec Fidji Simo backs Anthropic CEO's view on AI-driven cancer research
Former OpenAI executive Fidji Simo has expressed agreement with Anthropic CEO Dario Amodei on the importance of AI companies delivering real, measurable medical results. Simo stressed that firms must prove tangible outcomes rather than relying on marketing claims. She pointed to biological data as a major obstacle in developing AI-based treatments, while noting that cancer research holds an advantage due to large existing datasets. According to Simo, building the right infrastructure is critical to converting AI capabilities into practical medical solutions.
This is an AI-generated summary. ShortSingh links to the original source for the complete article.


Discussion (0)
Log in to join the discussion and vote.
Log in